Patent Assignment
Reel/Frame 023956/0604
Change of Name
Recorded: 2010-02-18
Pages: 3
Assignor
NASTECH PHARMACEUTICAL COMPANY INC.
Executed: 2008-06-10
Assignee
MDRNA, INC.
3830 MONTE VILLA PARKWAY, BOTHELL, WASHINGTON, 98021
Covered Properties
(3)
Compositions and Methods for Enhanced Mucosal Delivery of Parathyroid Hormone
Application:
11/744,745 →
Publication:
US 2007/0244049
Compositions for Intranasal Delivery of Human Insulin and Uses Thereof
Application:
12/376,205 →
Publication:
US 2009/0325860
Tight Junction Modulating Peptides for Enhanced Mucosal Delivery of Therapeutic Compounds
Application:
12/480,519 →
Publication:
US 2009/0274658
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 17, 2010
From: QUAY, STEVEN C.; COSTANTINO, HENRY R.; KLEPPE, MARY S.; LI, CHING-YUAN
To: NASTECH PHARMACEUTICAL COMPANY INC.
Reel/Frame 023949/0595 →
Assignment of Assignor's Interest
Feb 17, 2010
From: CUI, KUNYUAN; CHEN, SHU-CHIH; EITING, KRISTINE T.
To: NASTECH PHARMACEUTICAL COMPANY INC.
Reel/Frame 023949/0808 →
Release of Security Interest
Apr 14, 2014
From: GENESIS CAPITAL MANAGEMENT, LLC, AS AGENT
To: MARINA BIOTECH, INC.; CEQUENT PHARMACEUTICALS, INC.; MDRNA RESEARCH, INC.
Reel/Frame 032685/0158 →